My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 459

    1.

    Impaired fat oxidation after a single high-fat meal in insulin-sensitive nondiabetic individuals with a family history of type 2 diabetes.

    Heilbronn LK, Gregersen S, Shirkhedkar D, Hu D, Campbell LV.

    Diabetes. 2007 Aug;56(8):2046-53. Epub 2007 Apr 24.PMID: 17456847 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Regulation of skeletal muscle mitochondrial fatty acid metabolism in lean and obese individuals.

    Holloway GP, Bonen A, Spriet LL.

    Am J Clin Nutr. 2009 Jan;89(1):455S-62S. Epub 2008 Dec 3. Review.PMID: 19056573 [PubMed - indexed for MEDLINE]Related articles

    3.

    Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.

    Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR.

    Am J Physiol Endocrinol Metab. 2003 Aug;285(2):E354-62. Epub 2003 Apr 15.PMID: 12700163 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A short-term, high-fat diet up-regulates lipid metabolism and gene expression in human skeletal muscle.

    Cameron-Smith D, Burke LM, Angus DJ, Tunstall RJ, Cox GR, Bonen A, Hawley JA, Hargreaves M.

    Am J Clin Nutr. 2003 Feb;77(2):313-8.PMID: 12540388 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes.

    Watt MJ, Southgate RJ, Holmes AG, Febbraio MA.

    J Mol Endocrinol. 2004 Oct;33(2):533-44.PMID: 15525607 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus.

    Esposito K, Nappo F, Giugliano F, Di Palo C, Ciotola M, Barbieri M, Paolisso G, Giugliano D.

    Am J Clin Nutr. 2003 Dec;78(6):1135-40.PMID: 14668275 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Abnormal postprandial PYY response in insulin sensitive nondiabetic subjects with a strong family history of type 2 diabetes.

    Viardot A, Heilbronn LK, Herzog H, Gregersen S, Campbell LV.

    Int J Obes (Lond). 2008 Jun;32(6):943-8. Epub 2008 Mar 4.PMID: 18317469 [PubMed - indexed for MEDLINE]Related articles

    8.

    Dietary regulation of fat oxidative gene expression in different skeletal muscle fiber types.

    McAinch AJ, Lee JS, Bruce CR, Tunstall RJ, Hawley JA, Cameron-Smith D.

    Obes Res. 2003 Dec;11(12):1471-9.PMID: 14694211 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impaired cathepsin L gene expression in skeletal muscle is associated with type 2 diabetes.

    Huang X, Vaag A, Carlsson E, Hansson M, Ahrén B, Groop L.

    Diabetes. 2003 Sep;52(9):2411-8.PMID: 12941783 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Manipulation of dietary carbohydrate and muscle glycogen affects glucose uptake during exercise when fat oxidation is impaired by beta-adrenergic blockade.

    Zderic TW, Schenk S, Davidson CJ, Byerley LO, Coyle EF.

    Am J Physiol Endocrinol Metab. 2004 Dec;287(6):E1195-201. Epub 2004 Aug 17.PMID: 15315908 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effect of lipid oxidation on glucose utilization in humans.

    Jéquier E.

    Am J Clin Nutr. 1998 Mar;67(3 Suppl):527S-530S. Review.PMID: 9497164 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss.

    Corpeleijn E, Mensink M, Kooi ME, Roekaerts PM, Saris WH, Blaak EE.

    Obesity (Silver Spring). 2008 May;16(5):1025-32. Epub 2008 Feb 28.PMID: 18309299 [PubMed - indexed for MEDLINE]Related articles

    13.

    Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients.

    Lattuada G, Costantino F, Caumo A, Scifo P, Ragogna F, De Cobelli F, Del Maschio A, Luzi L, Perseghin G.

    Diabetologia. 2005 Apr;48(4):741-7. Epub 2005 Mar 10.PMID: 15759111 [PubMed - indexed for MEDLINE]Related articles

    14.

    Family history of diabetes links impaired substrate switching and reduced mitochondrial content in skeletal muscle.

    Ukropcova B, Sereda O, de Jonge L, Bogacka I, Nguyen T, Xie H, Bray GA, Smith SR.

    Diabetes. 2007 Mar;56(3):720-7.PMID: 17327442 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women.

    Holloway GP, Thrush AB, Heigenhauser GJ, Tandon NN, Dyck DJ, Bonen A, Spriet LL.

    Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1782-9. Epub 2007 Feb 20.PMID: 17311893 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status.

    Bruce CR, Anderson MJ, Carey AL, Newman DG, Bonen A, Kriketos AD, Cooney GJ, Hawley JA.

    J Clin Endocrinol Metab. 2003 Nov;88(11):5444-51.PMID: 14602787 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Coimmunoprecipitation of FAT/CD36 and CPT I in skeletal muscle increases proportionally with fat oxidation after endurance exercise training.

    Schenk S, Horowitz JF.

    Am J Physiol Endocrinol Metab. 2006 Aug;291(2):E254-60. Epub 2006 May 2.PMID: 16670153 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia.

    Smith AC, Mullen KL, Junkin KA, Nickerson J, Chabowski A, Bonen A, Dyck DJ.

    Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E172-81. Epub 2007 Mar 20.PMID: 17374701 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus.

    Heilbronn L, Smith SR, Ravussin E.

    Int J Obes Relat Metab Disord. 2004 Dec;28 Suppl 4:S12-21. Review.PMID: 15592481 [PubMed - indexed for MEDLINE]Related articles

    20.

    Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes.

    Perseghin G, Lattuada G, De Cobelli F, Esposito A, Costantino F, Canu T, Scifo P, De Taddeo F, Maffi P, Secchi A, Del Maschio A, Luzi L.

    Diabetologia. 2005 Dec;48(12):2615-21. Epub 2005 Nov 1.PMID: 16261312 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity